Cargando…
Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
In a move indicative of the enthusiastic support of precision medicine, the U.S. President Barack Obama announced the Precision Medicine Initiative in January 2015. The global precision medicine ecosystem is, thus, receiving generous support from the United States ($215 million), and numerous other...
Autores principales: | Alessandrini, Marco, Chaudhry, Mamoonah, Dodgen, Tyren M., Pepper, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072285/ https://www.ncbi.nlm.nih.gov/pubmed/27643672 http://dx.doi.org/10.1089/omi.2016.0122 |
Ejemplares similares
-
Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities
por: Chaudhry, Mamoonah, et al.
Publicado: (2016) -
Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort
por: Dodgen, Tyren M., et al.
Publicado: (2015) -
Allelic variants of the Melanocortin 4 receptor (MC4R) gene in a South African study group
por: Logan, Murray, et al.
Publicado: (2015) -
Pharmacogenomics of adverse drug reactions
por: Daly, Ann K
Publicado: (2013) -
Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)